Literature DB >> 33836750

On-demand pH-sensitive surface charge-switchable polymeric micelles for targeting Pseudomonas aeruginosa biofilms development.

Xiangjun Chen1, Rong Guo1, Changrong Wang1, Keke Li1, Xinyu Jiang1, Huayu He1, Wei Hong2.   

Abstract

Bacterial biofilm is the complicated clinical issues, which usually results in bacterial resistance and reduce the therapeutic efficacy of antibiotics. Although micelles have been drawn attention in treatment of the biofilms, the micelles effectively permeate and retain in biofilms still facing a big challenge. In this study, we fabricated on-demand pH-sensitive surface charge-switchable azithromycin (AZM)-encapsulated micelles (denoted as AZM-SCSMs), aiming to act as therapeutic agent for treating Pseudomonas aeruginosa (P. aeruginosa) biofilms. The AZM-SCSMs was composed of poly(L-lactide)-polyetherimide-hyd-methoxy polyethylene glycol (PLA-PEI-hyd-mPEG). It was noteworthy that the pH-sensitive acylhydrazone bond could be cleaved in acidic biofilm microenvironment, releasing the secondary AZM-loaded cationic micelles based on PLA-PEI (AZM-SCMs) without destroying the micellar integrity, which could tailor drug-bacterium interaction using micelles through electrostatic attraction. The results proved that positively charged AZM-SCMs could facilitate the enhanced penetration and retention inside biofilms, improved binding affinity with bacterial membrane, and added drug internalization, thus characterized as potential anti-biofilm agent. The excellent in vivo therapeutic performance of AZM-SCSMs was confirmed by the targeting delivery to the infected tissue and reduced bacterial burden in the abscess-bearing mice model. This study not only developed a novel method for construction non-depolymerized pH-sensitive SCSMs, but also provided an effective means for the treatment of biofilm-related infections.

Entities:  

Keywords:  Azithromycin; Biofilm penetration; Micelles; Surface charge-switchable

Year:  2021        PMID: 33836750      PMCID: PMC8034112          DOI: 10.1186/s12951-021-00845-0

Source DB:  PubMed          Journal:  J Nanobiotechnology        ISSN: 1477-3155            Impact factor:   10.435


  36 in total

1.  Why we don't get sick: the within-host population dynamics of bacterial infections.

Authors:  B R Levin; R Antia
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

Review 2.  The biofilm matrix.

Authors:  David G Allison
Journal:  Biofouling       Date:  2003-04       Impact factor: 3.209

3.  Size and Charge Adaptive Clustered Nanoparticles Targeting the Biofilm Microenvironment for Chronic Lung Infection Management.

Authors:  Yifan Gao; Jing Wang; Mengying Chai; Xu Li; Yongyan Deng; Qiao Jin; Jian Ji
Journal:  ACS Nano       Date:  2020-04-25       Impact factor: 15.881

4.  Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery.

Authors:  Li-Li Li; Jun-Hua Xu; Guo-Bin Qi; Xingzhong Zhao; Faquan Yu; Hao Wang
Journal:  ACS Nano       Date:  2014-04-14       Impact factor: 15.881

5.  Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection.

Authors:  Dissaya Pornpattananangkul; Li Zhang; Sage Olson; Santosh Aryal; Marygorret Obonyo; Kenneth Vecchio; Chun-Ming Huang; Liangfang Zhang
Journal:  J Am Chem Soc       Date:  2011-02-23       Impact factor: 15.419

6.  Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into Pseudomonas aeruginosa Biofilms in Lungs.

Authors:  Feng Wan; Søren S-R Bohr; Sylvia Natalie Kłodzińska; Haidar Jumaa; Zheng Huang; Tommy Nylander; Mikkel Boas Thygesen; Kasper Kildegaard Sørensen; Knud Jørgen Jensen; Claus Sternberg; Nikos Hatzakis; Hanne Mørck Nielsen
Journal:  ACS Appl Mater Interfaces       Date:  2019-12-17       Impact factor: 9.229

Review 7.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

8.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

Authors:  Chunbai He; Yiping Hu; Lichen Yin; Cui Tang; Chunhua Yin
Journal:  Biomaterials       Date:  2010-02-06       Impact factor: 12.479

Review 9.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

10.  Development of polycationic micelles as an efficient delivery system of antibiotics for overcoming the biological barriers to reverse multidrug resistance in Escherichia coli.

Authors:  Rong Guo; Keke Li; Jing Qin; Shengli Niu; Wei Hong
Journal:  Nanoscale       Date:  2020-05-28       Impact factor: 7.790

View more
  3 in total

1.  Drug Delivery Systems Based on Pluronic Micelles with Antimicrobial Activity.

Authors:  Corina Popovici; Marcel Popa; Valeriu Sunel; Leonard Ionut Atanase; Daniela Luminita Ichim
Journal:  Polymers (Basel)       Date:  2022-07-25       Impact factor: 4.967

Review 2.  Delivering macrolide antibiotics to heal a broken heart - And other inflammatory conditions.

Authors:  Vincent J Venditto; David J Feola
Journal:  Adv Drug Deliv Rev       Date:  2022-03-30       Impact factor: 17.873

3.  Layer-by-layer coated hybrid nanoparticles with pH-sensitivity for drug delivery to treat acute lung infection.

Authors:  Ji Luo; Xiaobo Li; Siyuan Dong; Peiyao Zhu; Wenke Liu; Shuguang Zhang; Jiang Du
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.